Publishing holiday for MLK Day

It's been a hectic week for FierceBiotech. The J.P. Morgan conference is always a great way to see how things are shaping up for the year. The underlying message: We may not have boom times this year, but most CEOs are in an upbeat mood. The outlook was pretty shaky a year ago, with all sorts of bleak prognostications.

The stock market is taking a holiday on Monday in observation of Martin Luther King Day, and so will we. We'll be back for more biotech news and views on Tuesday. But I do plan to keep up with the occasional tweet. I'd encourage you to sign up if you want to find out a little more about what I'm thinking in regards to the biotech world. - John Carroll (twitter | email)

Suggested Articles

I-MAB's anti-GM-CSF drug works "upstream" in inflammation pathways, potentially blocking several dangerous cytokines in COVID-19, executives…

Antibe's lead drug beat placebo at reducing osteoarthritis pain, boosting its case as an alternative to NSAIDs, commonly used to treat the condition.

The trial marks the start of a new phase of the response to SARS-CoV-2 in which people will receive drugs designed specifically for the virus.